KYOYEON IP LAW FIRM


Kyoyeon IP Law Office is dedicated to transforming low-value patents into high-value, commercially viable rights through high-quality patent specifications and strategic IP management. They emphasize the importance of high-quality patent documentation from the outset to ensure successful commercialization and dispute readiness. The firm is committed to connecting valuable patents to business success and advocates for the protection of high-value inventions to foster innovation and competitiveness.

Industries

biotechnology
legal
pharmaceutical
professional-services

Nr. of Employees

small (1-50)

KYOYEON IP LAW FIRM

Yeoksamdong, Seoul-t'ukpyolsi, South Korea, Asia


Services

Preparation and filing of patent applications and prosecution management to secure patent grants.

Representation in invalidation trials, claim scope confirmation proceedings, and litigation before patent courts and higher courts.

Technical and legal review of IP assets to support transactions, investments, and licensing negotiations.

Participation in licensing deal structuring, networked marketing of technologies, and support for technology transfer.

Conducting prior art searches, patent landscape analysis, and white-space identification to inform filing and commercialization decisions.

Drafting warning letters, responses, and other enforcement-related correspondence in infringement and pre-litigation contexts.

Expertise Areas

  • Patent prosecution and specification drafting
  • Intellectual property litigation and administrative trials
  • Pharmaceutical and biotechnology patenting
  • Patent portfolio strategy and management
  • Show More (4)

Key Technologies

  • Small-molecule therapeutics
  • Biologics and antibody therapeutics
  • Bispecific antibodies
  • Antibody-drug conjugates (ADC)
  • Show More (5)

News & Updates

A patent for a new drug developed by Celltrion and the Korea Disease Control and Prevention Agency was registered in just 19 days, highlighting rapid patent processing.

A detailed patent strategy for Laser Tivant, with patent portfolio completion at each stage of technology transfer.

Guidance on utilizing the self-notification system and avoiding public disclosure before patent application.

Understanding the timing and scope restrictions of patent correction and amendment.

Start of domestic research on PROTAC platform and patent rights at the platform level.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.